Patient age | 62 years and 8 months | 62 years and 10 months | 63 years and 6 months |
---|
T.Bil6) (mg/dl) | 0.4 | 0.4 | 0.9 |
D.Bil5) (mg/dl) | 0.1 | 0.1 | 0.4 |
AST3) (IU/l) | 37 | 12 | 56 |
ALT2) (IU/l) | 28 | 28 | 67 |
AFP1) (ng/ml) | 2.6 | No data | 1.8 |
CEA4) (ng/ml) | 4.8 | No data | 7 |
CA19-9 (U/ml) | 15.8 | No data | 301.2 |
- Her liver function tests were within the normal range at 62 years and 8 months old and 62 years and 10 months old. Her liver function test results showed slight abnormalities at 63 years and 6 months old. Among tumor markers assessed at that time, CEA and CA19-9 levels were elevated; both markers were within normal range 10 months before
- AFP1) α-fetoprotein, ALT2) alanine aminotransferase, AST3) aspartate aminotransferase, CEA4) carcinoembryonic antigen, D. Bil5) direct bilirubin, T. Bil6) total bilirubin